Human CXCL11 Protein

<strong>Human CXCL11 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2012083_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1 mg/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> IP-9 protein, CXCL 11 protein, SCYB11 protein, H174 protein, C-X-C motif chemokine 11 protein, SCYB9B protein, I-TAC protein, CXCL-11, IP9 protein, MGC102770 protein, b-R1 protein, CXCL 11, CXCL11, CXCL-11 protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy Cancer Treat Rev. 2018 Feb;63:40-47._x000D_ 2: Koper OM, Kamińska J, Sawicki K, Kemona H. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration Adv Clin Exp Med. 2018 Jun;27(6):849-856._x000D_ 3: Karin N. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond Front Immunol. 2020 May 29;11:976._x000D_ 4: Bergemalm D, Andersson E, Hultdin J, Eriksson C, Rush ST, Kalla R, Adams AT, Keita ÅV, D'Amato M, Gomollon F, Jahnsen J; IBD Character Consortium, Ricanek P, Satsangi J, Repsilber D, Karling P, Halfvarson J. Systemic Inflammation in Preclinical Ulcerative Colitis Gastroenterology. 2021 Nov;161(5):1526-1539.e9._x000D_ 5: Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, Sun BY, Wang ZT, Zhou J, Fan J, Qiu SJ, Yi Y. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis Cell Death Dis. 2021 Mar 11;12(3):260._x000D_ 6: Hwang HJ, Lee YR, Kang D, Lee HC, Seo HR, Ryu JK, Kim YN, Ko YG, Park HJ, Lee JS. Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells Cancer Lett. 2020 Oct 10;490:100-110._x000D_ 7: Vollmer T, Schlickeiser S, Amini L, Schulenberg S, Wendering DJ, Banday V, Jurisch A, Noster R, Kunkel D, Brindle NR, Savidis I, Akyüz L, Hecht J, Stervbo U, Roch T, Babel N, Reinke P, Winqvist O, Sherif A, Volk HD, Schmueck-Henneresse M. The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer Sci Transl Med. 2021 Jan 13;13(576):eabb3735._x000D_ 8: Gao Q, Zhang Y. CXCL11 Signaling in the Tumor Microenvironment Adv Exp Med Biol. 2021;1302:41-50._x000D_ 9: Hueso L, Ortega R, Selles F, Wu-Xiong NY, Ortega J, Civera M, Ascaso JF, Sanz MJ, Real JT, Piqueras L. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis Int J Obes (Lond). 2018 Aug;42(8):1406-1417._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33502606">10: Puchert M, Koch C, Zieger K, Engele J. Identification of CXCL11 as part of chemokine network controlling skeletal muscle development Cell Tissue Res. 2021 May;384(2):499-511. </a>_x000D_ _x000D_ <strong>Products Related to Human CXCL11 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>